BioCryst Pharmaceuticals Inc (BCRX) Insider Trading
- $10,606,554.40
- $41,482,619.76
- Aug. 13, 2025
- Thomas R Staab II
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 4, 2015 | VP | 10,495 | $10.50 | Sell | $110,197.50 | |
| Feb. 20, 2015 | Director | 10,000 | $10.27 | Buy | $102,700.00 | |
| Dec. 30, 2014 | CMO | 128,399 | $12.36 | Sell | $1,587,011.64 | |
| Dec. 29, 2014 | CFO | 9,500 | $12.56 | Sell | $119,320.00 | |
| Dec. 29, 2014 | CMO | 105,295 | $12.43 | Sell | $1,308,816.85 | |
| Aug. 27, 2014 | CFO | 10,000 | $13.58 | Sell | $135,800.00 | |
| July 1, 2014 | CFO | 3,125 | $13.00 | Sell | $40,625.00 | |
| June 23, 2014 | CFO | 3,125 | $12.49 | Sell | $39,031.25 | |
| June 17, 2014 | CFO | 3,125 | $12.00 | Sell | $37,500.00 | |
| March 14, 2014 | CFO | 3,125 | $11.24 | Sell | $35,125.00 | |
| March 6, 2014 | Director | 12,665 | $12.69 | Sell | $160,718.85 | |
| Nov. 12, 2013 | Director | 3,000 | $6.19 | Buy | $18,570.00 | |
| Aug. 1, 2013 | Major Shareholder | 1,136,364 | $4.40 | Buy | $5,000,001.60 | |
| March 5, 2013 | Director | 3,000 | $1.23 | Buy | $3,690.00 | |
| Dec. 14, 2012 | Director | 20,000 | $1.51 | Buy | $30,200.00 |
Insiders are both buying and selling BioCryst Pharmaceuticals Inc stock.
The insider traders at BioCryst Pharmaceuticals Inc are: Thomas R Staab II, Lynne Powell, William P Sheridan, Yarlagadda S Babu, Bros. Advisors Lp Baker, George B Abercrombie, Jon P Stonehouse, Alane P Barnes, Anthony Doyle, Helen M Thackray, Nancy J Hutson, Steve Aselage, Michael L Jones, Machelle Sanders, Peder Jensen, Steven K Galson, Theresa Heggie, Amy E Mckee, Thomas Staab II, Felix Baker, Fred E Cohen, Vincent Milano, George Abercrombie, George B. Abercrombie, Alan G Levin, Kenneth B Lee Jr, Kenneth Lee, Jr., and Megan Sniecinski
The most active insider trader at BioCryst Pharmaceuticals Inc is Thomas R Staab II with 35 trades.
Bros. Advisors Lp Baker has sold the most BioCryst Pharmaceuticals Inc stock with a total value of $40,465,900.00.
Felix Baker has bought the most BioCryst Pharmaceuticals Inc stock with a total value of $10,000,003.20.
The most recent insider trade for BioCryst Pharmaceuticals Inc was on Aug. 13, 2025.
The single biggest insider buy for BioCryst Pharmaceuticals Inc was from Felix Baker with a total value of $5,000,001.60 on Aug. 1, 2013.
The single biggest insider sell for BioCryst Pharmaceuticals Inc was from Bros. Advisors Lp Baker with a total value of $20,232,950.00 on Aug. 16, 2016.